ArticleScientific reports2025
Risk factors and transitional probability of clinical events in Korean CKD patients using the multistate model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unmet clinical need in patients with acute kidney injury and acute kidney disease: insights from a Korean multicenter cohort.Kidney research and clinical practice · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Korean chronic kidney disease (CKD) patients have relatively low cardiovascular disease (CVD) and high end stage kidney disease (ESKD) incidence rates. Using the multi-state model this study analyzed the 5- and 10-year cumulative hazard estimates, transition probabilities and risk factors associated with the five clinical transitions; ESKD, CVD, CVD to death, ESKD to death and death. CKD stages 1-4 patients from the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease cohort were included. Multivariable multi-state model analysis was performed to investigate the study outcomes associated with the five transitions. Among the 1502 patients (median age 54 years, male 61.3%), the overall prevalence of clinical events were: ESKD (22.6%), CVD (7.5%), death after ESKD (3.6%), death (3.3%) and death after CVD (1.2%). Patients who experienced intermediate ESKD event had higher risk of death than those who experienced CVD event (10-year cumulative hazard: 0.35; 95% CI: 0.23, 0.48 vs. 0.27; 95% CI: 0.15, 0.40). The 10-year transition probability was highest for enrollment to ESKD (0.27; 95% CI: (0.23, 0.31)) followed by enrollment to CVD (0.08; 95% CI: 0.07, 0.10). Different clinical risk factors were associated with each of the five transitions. Patients who experienced intermediate ESKD event were more exposed to death risk than those who experienced CVD and the highest 10-year progression probability was for enrollment to ESKD followed by death after ESKD. Different risk factors were associated with varying transitions. These findings correlate with the distinctive clinical features of Korean CKD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.